Quarterly report [Sections 13 or 15(d)]

Warrants

v3.25.1
Warrants
3 Months Ended
Mar. 31, 2025
Warrants [Abstract]  
WARRANTS

NOTE 8 – WARRANTS

 

As of March 31, 2025, the fair value of the Public Warrants was approximately $0.364 per Public Warrant based on the closing price of the warrants on The Nasdaq Capital Market. The fair value of the Representative Warrants was approximately $0.379 per Representative Warrant, which was based on the relative fair value to the Public Warrants.

 

The following table summarizes the Company’s outstanding warrants:

 

Exercise Price     Number of warrants     Weighted-average remaining contractual term (years)     Weighted average exercise price  
$ 3.85       2,439,026       2.76          
$ 5.13       85,366       4.51          
$ 8.13       1,500       8.92          
$ 20.00       433,999       1.65          
$ 37.60       100,001       2.38          
$ 120.00       13,800       1.46          
$ 125.00       220,000       1.46          
          3,293,692       2.55       15.62  

 

For the three months ended March 31, 2025 and 2024, total stock-based compensation expense related to the Company’s warrants was approximately $1,573 and $787, respectively, and is recognized within general and administrative expense on the condensed consolidated statements of operations and comprehensive loss.

 

During the three months ended March 31, 2025, the Company issued no warrants.

 

During the three months ended March 31, 2024, the Company issued warrants to purchase an aggregate of 1,500 shares of Common Stock in exchange for consulting services. The warrants were issued on March 1, 2024 and became exercisable in twelve equal monthly installments commencing on April 1, 2024 at $8.13 per share. The warrants expire ten years from the date of issuance.

 

No warrants were expired/cancelled or exercised during the three months ended March 31, 2025 and 2024.